7 Participants Needed

Exoskeleton-Assisted Therapy for Stroke

BC
Overseen ByBrittney C Muir, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Stroke is the leading cause of adult-onset disability, and affects 15,000 Veterans each year. Successful rehabilitation and recovery following a stroke requires therapy including repetitive task training. However, repetitive task training can be draining for both the clinician and the patient as it requires the participant to complete many repetitions of the same task and those repetitions can be difficult to accomplish with appropriate technique. Robot-mediated repetitive task training has the potential to facilitate the clinical delivery of proven rehabilitation programs to Veterans in need and recently a new exoskeleton has been developed, called Harmony, which can deliver bimanual 3D arm therapy. The investigators propose to develop and test two novel controllers', synergy avoidance and task assistance, that use promising neurological basis for training to facilitate repetitive task training while ensuring correct movement patterns in acute and sub-acute stage stroke patients. This has the potential to improve Veterans' activities of daily living and quality of life.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the Exoskeleton-Assisted Therapy for Stroke treatment?

Research shows that robotic exoskeletons can help improve movement and walking in stroke patients by providing necessary assistance while encouraging active participation. Studies have demonstrated improvements in motor control and daily activities, suggesting that exoskeletons can be a promising tool for stroke rehabilitation.12345

Is exoskeleton-assisted therapy safe for humans?

Research shows that exoskeleton-assisted therapy is generally safe for humans, with no adverse effects reported in studies involving stroke survivors. Participants in these studies completed therapy sessions without any reported issues, indicating the treatment's safety in clinical settings.26789

How does the Exoskeleton-Assisted Therapy for Stroke differ from other treatments for stroke recovery?

The Exoskeleton-Assisted Therapy for Stroke is unique because it uses a robotic exoskeleton to provide targeted assistance to patients, allowing them to perform movements with minimal help, which encourages active participation and potentially faster recovery. This approach contrasts with traditional therapies that may not offer the same level of personalized, adaptive support and motivation through interactive elements like virtual reality games.1451011

Research Team

BC

Brittney C Muir, PhD

Principal Investigator

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Eligibility Criteria

This trial is for stroke survivors over 18 who fit within the Harmony exoskeleton's size limits. Participants should have moderate to severe upper limb impairment, as measured by a specific score, and must have had their stroke recently (1 week to 6 months prior). Those with unstable health conditions, severe joint pain in the limbs, cognitive or language barriers, multiple strokes, seizures or significant communication issues cannot join.

Inclusion Criteria

You need to have body measurements that fit within the Harmony system's limits.
I had a stroke between 1 week and 6 months ago.
My arm and hand movement is moderately to severely limited.
See 1 more

Exclusion Criteria

You have trouble communicating effectively.
I have had more than one stroke.
I do not have unstable heart, bone, or nerve conditions.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Early Testing

Up to 5 participants testing the SA controller in one visit

1 day
1 visit (in-person)

Treatment

Participants complete high repetitions of reaching tasks once per day while wearing the Harmony exoskeleton for three weeks

3 weeks
Daily sessions

Follow-up

Participants are monitored for changes in joint coordination and compensatory strategies after the intervention

4 weeks

Treatment Details

Interventions

  • SA controller
  • TA controller
Trial OverviewThe study is testing two new control systems for an arm therapy exoskeleton called Harmony. These systems are designed to help patients perform repetitive tasks correctly during rehabilitation after a stroke. The goal is to see if these controllers can improve daily living activities and quality of life for Veterans.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: early testingExperimental Treatment1 Intervention
up to 5 participants testing the SA controller in one visit
Group II: SA controllerExperimental Treatment2 Interventions
Synergy assistance controller

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Findings from Research

A novel adaptive controller for robot-aided movement training after stroke was developed, featuring high mechanical compliance and the ability to provide only the necessary assistance to patients, enhancing their engagement in therapy.
Tests with the Pneu-WREX robotic device showed that the 'assist-as-needed' approach improved patient participation and demonstrated the natural tendency of patients to rely on the robot for support when they could, which helps in motor learning and rehabilitation.
Optimizing compliant, model-based robotic assistance to promote neurorehabilitation.Wolbrecht, ET., Chan, V., Reinkensmeyer, DJ., et al.[2022]
Powered robotic exoskeletons are a safe intervention for gait rehabilitation in stroke patients, showing meaningful improvements in walking outcomes, especially in those who are in the sub-acute phase of recovery.
While exoskeleton training is equivalent to traditional therapy for chronic stroke patients, sub-acute patients may benefit more from this technology, indicating a need for further rigorous trials to establish its clinical effectiveness.
Powered robotic exoskeletons in post-stroke rehabilitation of gait: a scoping review.Louie, DR., Eng, JJ.[2023]
The Armule exoskeleton, designed with a postural synergy concept, significantly improved motor control and activities of daily living in eight participants with hemiplegia after four weeks of therapy, as measured by the Fugl-Meyer Assessment and other clinical tests.
Participants showed notable improvements in both clinical measures (e.g., FMA-UE increased by 11.50 points) and kinematic metrics, suggesting that the exoskeleton's design effectively supports natural movement patterns during rehabilitation.
Preliminary Assessment of a Postural Synergy-Based Exoskeleton for Post-Stroke Upper Limb Rehabilitation.He, C., Xiong, CH., Chen, ZJ., et al.[2021]

References

Optimizing compliant, model-based robotic assistance to promote neurorehabilitation. [2022]
Powered robotic exoskeletons in post-stroke rehabilitation of gait: a scoping review. [2023]
Preliminary Assessment of a Postural Synergy-Based Exoskeleton for Post-Stroke Upper Limb Rehabilitation. [2021]
Hand function recovery in chronic stroke with HEXORR robotic training: A case series. [2020]
An assistive control approach for a lower-limb exoskeleton to facilitate recovery of walking following stroke. [2022]
Exoskeleton-Assisted Sit-to-Stand Training Improves Lower-Limb Function Through Modifications of Muscle Synergies in Subacute Stroke Survivors. [2023]
Preliminary assessment of a lower-limb exoskeleton controller for guiding leg movement in overground walking. [2018]
Exploring the Capabilities of Harmony for Upper-Limb Stroke Therapy. [2020]
Development of a Low-Cost, Modular Muscle-Computer Interface for At-Home Telerehabilitation for Chronic Stroke. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Multi-Objective Optimization-Based Assist-as-Needed Controller for Improved Quality of Assistance in Rehabilitation Robotics. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
An Exoneuromusculoskeleton for Self-Help Upper Limb Rehabilitation After Stroke. [2022]